Philadelphia-Israel Chamber of Commerce member Teva Pharmaceutical Industries Ltd., will host members of the Chamber and guests for a special program on November 16, 6:00-8:00 PM.
|Rivka Kreitman PhD. SVP., Head of Global Search and Evaluation and Acting Head of Global Specialty Regulatory Affairs – welcoming remarks|
|Fernando Sallés, PhD. VP, Head of Global Search – “Teva Not So Generic”|
|Ian Reynolds PhD VP.,Head, Discovery Research – Making Small Molecules Into Big Products – Drug Discovery at Teva”|
Teva, established in 1901 and headquartered in Israel, provides medicines for over 200 million people each day. It is not just one of the world’s largest generic medicines providers but a significant specialty pharmaceutical company with a branded presence and focus in key core therapeutic areas including pain, migraine, movement and neurodegenerative disorders and respiratory illnesses. Teva’s specialty business spans the entire value chain of pharmaceutical development from discovery research through clinical development to commercialization. Teva invites you to meet with key senior staff and learn about Teva’s activities in these R&D areas. Including recent advances in patient engagement and digital medicine.
Join us on November 16, 6:00-8:00 PM!
Participation by registration only!
Registration is closed! Thank you!